stella
beta
A Trial on the Recurrence Free Survival Rate of Type I AIP With High-risk of Recurrence — Stella
Recruiting
Back to Type 1 AIP trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
China
Ruijin Hospital, Shanghai, Shanghai Municipality
View full record on ClinicalTrials.gov